帝人株式会社の持分法適用関連会社の異動に関するお知らせ

This document announces that Teijin Limited has resolved to transfer its shares in Esteve Teijin Healthcare, S.L. to Oximesa S.L.U. The reason for the transfer is based on Esteve's intention to focus on healthcare areas other than home healthcare services, leading Teijin to conclude that the share transfer is the best option for further growth of both Teijin and ETH. The transfer is scheduled to be executed in late March 2025, and it is expected to record approximately 7 billion yen as gains from the sale of shares in the consolidated financial results for the fiscal year ending March 2025.